OnCo

RANBP2 (E3 SUMO-protein ligase RanBP2) is an enzyme. The public catalogues list it as an oncogene driver, a tumour suppressor and a fusion partner, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Lung cancer, Hepatocellular carcinoma, Renal cell carcinoma and 5 more. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.

Biology

E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I. Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates. Binds single-stranded RNA (in vitro). May bind DNA. Component of the nuclear export pathway. Specific docking site for the nuclear export factor exportin-1. Location: Nucleus; Nucleus membrane; Nucleus, nuclear pore complex; Nucleus envelope (UniProt). Locus 2q13 (HGNC).

Where it is found
  • Lung cancer: Open Targets association 0.59 with lung cancer (MONDO_0008903)
  • Hepatocellular carcinoma: IntOGen driver in 2 cohorts (HCC)
  • Renal cell carcinoma: IntOGen driver in 1 cohort (CCRCC)
  • Pheochromocytoma and paraganglioma: IntOGen driver in 1 cohort (PGNG)
  • Skin cancer: Open Targets association 0.55 with skin cancer (MONDO_0002898)
  • Breast cancer: Open Targets association 0.52 with breast cancer (MONDO_0007254)
Class: enzyme · Gene: RANBP2 · Facts checked 2026-09-23 · Target page

External identifiers

Built from HGNC, Ensembl, UniProt and ChEMBL ids

Products by modality and phase

Browse products →

No product in the corpus is aimed at this target yet.

No trial in the corpus names this target or one of its products.

Resistance routes

Unaddressed routes →

The resistance atlas has no route that names this target.

No pathway diagram carries this target as a node.

Companion diagnostics

Assay registry →

No companion diagnostic in the registry measures this target.

Preclinical models

All models →

No model entry for this target yet; check the cancer entries on the models page.

No open questions recorded for this target yet. Suggest one.

Literature

Preprints →
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this target: (TITLE:"RANBP2" OR ABSTRACT:"RANBP2" OR TITLE:"RAN binding protein 2" OR ABSTRACT:"RAN binding protein 2" OR TITLE:"E3 SUMO-protein ligase RanBP2" OR ABSTRACT:"E3 SUMO-protein ligase RanBP2" OR TITLE:"NUP358" OR ABSTRACT:"NUP358" OR TITLE:"ADANE" OR ABSTRACT:"ADANE" OR TITLE:"ANE1" OR ABSTRACT:"ANE1") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about RANBP2, not a curated reading list.

Export

The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/ranbp2.json. Licence CC BY-NC 4.0.